Sense Biodetection has raised a $50 million Series B investment to advance commercialization of its Veros covid-19 product and continue development of a portfolio of instrument-free, rapid molecular tests.
Read More
A Q&A with Dr. Ankur Mutreja and Dr Deepak Nath in Politico covers vaccines, testing, and tackling covid-19 in Europe and across the globe.
Read More
With eight new configurations, cobas pro integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs.
Read More
Leinco will gain exclusive access to certain SARS-CoV-2 antibodies directed against the virus’ N protein and make the antibodies commercially available.
Read More
Patients with covid-19 had lower lipid levels in sebum samples.
Read More